ASM-024

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameASM-024
Drug Alias NameASM-024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonistsMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptorNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsmacure
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsmacure Ltée
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A